Literature DB >> 29348073

Rate of switch from bipolar depression into mania after morning light therapy: A historical review.

Francesco Benedetti1.   

Abstract

Light therapy (LT) is efficacious for bipolar depression with effect sizes equivalent to those in antidepressant pharmacotherapy trials. Patients with bipolar disorder (BD) show a 15-40% rate of manic switches during antidepressant drug treatment. The rate of manic switches during LT has never been estimated. We searched all the literature studies reporting effects of antidepressant LT in BD. 41 studies described 799 patients with BD treated with antidepressant LT, from among which 7 (0.9%) switched into mania and 11 (1.4%) switched into hypomania. The method of assessment of treatment-emergent symptoms significantly influenced the detection of switches into mania: 0% when no method was reported, 0.8% with clinical mental state examination, and 3% with rating scales (χ2 = 14.805, d.f. 4, p = 0.005). The rate of switch increased to 18.8% when considering the 16 patients with rapid-cycling BD. Switches occurred independent of treatment modality (light intensity, duration, and circadian timing of administration). The available literature shows that the highest reported rate of switch from bipolar depression into mania after LT is closely similar to the 4% switch rate expected during the placebo treatment of BD, thus not justifying specific concerns when using this treatment option.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressant; Bipolar disorder; Light therapy; Mania; Switch

Mesh:

Substances:

Year:  2018        PMID: 29348073     DOI: 10.1016/j.psychres.2018.01.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Sleep and Circadian Rhythm Disorder in Bipolar Affective Disorder.

Authors:  Attia Ahmad; Kirstie N Anderson; Stuart Watson
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Raymond W Lam; Minnie Y Teng; Young-Eun Jung; Vanessa C Evans; John F Gottlieb; Trisha Chakrabarty; Erin E Michalak; Jill K Murphy; Lakshmi N Yatham; Dorothy K Sit
Journal:  Can J Psychiatry       Date:  2019-12-12       Impact factor: 4.356

3.  Treating winter depressive episodes in bipolar disorder: an open trial of light therapy.

Authors:  Lotte J E van Hout; Lisette E P Rops; Claudia J P Simons
Journal:  Int J Bipolar Disord       Date:  2020-06-01

4.  Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I / II Trial.

Authors:  Pierre Alexis Geoffroy; El Mountacer Billah El Abbassi; Julia Maruani; Bruno Etain; Michel Lejoyeux; Ali Amad; Philippe Courtet; Caroline Dubertret; Philip Gorwood; Guillaume Vaiva; Frank Bellivier; Sylvie Chevret
Journal:  Psychiatry Investig       Date:  2018-11-26       Impact factor: 2.505

5.  Dynamic LED-light versus static LED-light for depressed inpatients: study protocol for a randomised clinical study.

Authors:  Carlo Volf; Anne Sofie Aggestrup; Paul Michael Petersen; Carsten Dam-Hansen; Ulla Knorr; Ema Erkocevic Petersen; Janus Engstrøm; Janus C Jakobsen; Torben Skov Hansen; Helle Østergaard Madsen; Ida Hageman; Klaus Martiny
Journal:  BMJ Open       Date:  2020-01-26       Impact factor: 2.692

Review 6.  Adjunctive bright light therapy for treating bipolar depression: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Hirofumi Hirakawa; Takeshi Terao; Masaaki Muronaga; Nobuyoshi Ishii
Journal:  Brain Behav       Date:  2020-10-09       Impact factor: 2.708

Review 7.  Sleep deprivation as treatment for depression: Systematic review and meta-analysis.

Authors:  Michael Ioannou; Constanze Wartenberg; Josephine T V Greenbrook; Tomas Larson; Kajsa Magnusson; Linnea Schmitz; Petteri Sjögren; Ida Stadig; Zoltán Szabó; Steinn Steingrimsson
Journal:  Acta Psychiatr Scand       Date:  2020-12-27       Impact factor: 6.392

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.